Back to Results
First PageMeta Content
Perception / European Federation of Pharmaceutical Industries and Associations / Chronic pain / Boehringer Ingelheim / AstraZeneca / Eli Lilly and Company / Pharmaceutical industry / Nociception / Mind / Pain


IMI 1ST CALL PROJECTS: EFFICACY EUROPAIN UNDERSTANDING CHRONIC PAIN AND IMPROVING ITS TREATMENT SUMMARY:
Add to Reading List

Document Date: 2011-04-01 08:27:19


Open Document

File Size: 87,38 KB

Share Result on Facebook

City

Kiel / Heidelberg / Basingstoke / Barcelona / Sandwich / Ingelheim / London / Södertälje / Brussels / Bochum / Oxford / /

Company

Eli Lilly / Aventis / Spain UCB Pharma SA / Sweden (Project Coordinator) Boehringer Ingelheim International GmbH / Sanofi / AstraZeneca AB / Germany Pfizer Limited / Wyeth Pharmaceuticals / /

Continent

Europe / /

Country

Germany / United Kingdom / Denmark / /

Currency

EUR / /

Facility

Kings College / United Kingdom University of Oxford / United Kingdom Imperial College of Science / University Hospital Bergmannsheil Bochum / United Kingdom University College / King's College / /

IndustryTerm

active pharmaceutical / /

MedicalCondition

chronic pain / pain / depression / /

Organization

Germany Ruprecht-Karls-Universität Heidelberg / College of Science / United Kingdom University of Oxford / Kings College / London / University College London / London / European Federation of Pharmaceutical Industries and Associations / King's College London / London / Johann Wolfgang Goethe Universität / /

Person

Johann Wolfgang Goethe / /

/

Position

Coordinator / /

Product

nicotine / /

Technology

Neuroscience Technologies / /

URL

www.imi.europa.eu / /

SocialTag